BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 11079584)

  • 1. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
    Meltzer CC; Luketich JD; Friedman D; Charron M; Strollo D; Meehan M; Urso GK; Dachille MA; Townsend DW
    Clin Nucl Med; 2000 Nov; 25(11):882-7. PubMed ID: 11079584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of positron emission tomography in staging esophageal cancer.
    Luketich JD; Schauer PR; Meltzer CC; Landreneau RJ; Urso GK; Townsend DW; Ferson PF; Keenan RJ; Belani CP
    Ann Thorac Surg; 1997 Sep; 64(3):765-9. PubMed ID: 9307471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].
    Kneist W; Schreckenberger M; Bartenstein P; Grünwald F; Oberholzer K; Junginger T
    Chirurg; 2003 Oct; 74(10):922-30; discussion 929-30. PubMed ID: 14605734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
    Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
    J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer.
    Tan R; Yao SZ; Huang ZQ; Li J; Li X; Tan HH; Liu QW
    Asian Pac J Cancer Prev; 2014; 15(18):7719-24. PubMed ID: 25292052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
    Westerterp M; Van Westreenen HL; Sloof GW; Plukker JT; Van Lanschot JJ
    Scand J Gastroenterol Suppl; 2006; (243):116-22. PubMed ID: 16782630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
    Kato H; Kuwano H; Nakajima M; Miyazaki T; Yoshikawa M; Ojima H; Tsukada K; Oriuchi N; Inoue T; Endo K
    Cancer; 2002 Feb; 94(4):921-8. PubMed ID: 11920459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.
    Yoon YC; Lee KS; Shim YM; Kim BT; Kim K; Kim TS
    Radiology; 2003 Jun; 227(3):764-70. PubMed ID: 12773680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
    Flamen P; Lerut A; Van Cutsem E; De Wever W; Peeters M; Stroobants S; Dupont P; Bormans G; Hiele M; De Leyn P; Van Raemdonck D; Coosemans W; Ectors N; Haustermans K; Mortelmans L
    J Clin Oncol; 2000 Sep; 18(18):3202-10. PubMed ID: 10986052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of (18)F-FDG PET/CT on the therapeutic management in the initial staging of the esophageal cancer].
    Pifarré-Montaner P; Fernández-León A; de Juan R; del Ama-Salvador ME; Galán M; Gámez-Cenzano C; Sans M
    Rev Esp Med Nucl; 2009; 28(3):101-5. PubMed ID: 19558949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT.
    Malik V; Harmon M; Johnston C; Fagan AJ; Claxton Z; Ravi N; O'Toole D; Muldoon C; Keogan M; Reynolds JV; Meaney JF
    Dig Surg; 2015; 32(5):397-408. PubMed ID: 26315570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer.
    Yuan S; Yu Y; Chao KS; Fu Z; Yin Y; Liu T; Chen S; Yang X; Yang G; Guo H; Yu J
    J Nucl Med; 2006 Aug; 47(8):1255-9. PubMed ID: 16883002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Positron emission tomography for the preoperative staging of esophageal carcinoma].
    Junginger T; Kneist W; Schreckenberger M; Menzel C; Oberholzer K; Bartenstein P
    Dtsch Med Wochenschr; 2002 Sep; 127(38):1935-41. PubMed ID: 12239652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
    Manabe O; Hattori N; Hirata K; Itoh K; Hosokawa M; Takahashi H; Oyama-Manabe N; Tamaki N
    J Nucl Med; 2013 May; 54(5):670-6. PubMed ID: 23516310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls of positive findings in staging esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography.
    van Westreenen HL; Heeren PA; Jager PL; van Dullemen HM; Groen H; Plukker JT
    Ann Surg Oncol; 2003 Nov; 10(9):1100-5. PubMed ID: 14597450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of distant metastases in esophageal cancer with (18)F-FDG PET.
    Heeren PA; Jager PL; Bongaerts F; van Dullemen H; Sluiter W; Plukker JT
    J Nucl Med; 2004 Jun; 45(6):980-7. PubMed ID: 15181133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
    Katsoulis IE; Wong WL; Mattheou AK; Damani N; Chambers J; Livingstone JI
    Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.